-
2024-515276-12-00
5
2020-07-01
Postpartum Hemorrhage
-
2024-515584-56-00
5
2020-06-19
Cutibacterium acnes infection in shoulder arthroplasty with males
-
2024-511620-13-00
4
2020-06-05
Patient presenting with:
- ectopic ossification secondary to iPPSD2 or
-
2022-501454-11-00
5
2020-02-05
standard risk ALK-positive anaplastic large cell lymphoma (ALCL)
-
2023-507256-76-00
6
2020-01-14
Ulcerative colitis
-
2024-516266-11-00
5
2020-01-06
yeast intra-abdominal infection, peritonitis
-
2023-508926-91-00
5
2019-12-05
Stage IV childhood renal tumour with pulmonary +/- non-pulmonary
metas
-
2023-509699-41-00
9
2019-11-22
Recurrent or Refractory Leukemias, Lymphomas, and Solid Tumors
-
2023-507794-17-00
4
2019-11-11
Childhood Epilepsy
-
2023-509343-27-00
11
2019-10-28
C3 Glomerulopathy or idiopathic immune-complex membranoproliferative g
-
2024-514156-33-00
5
2019-08-20
Patients in remission for granulomatosis with polyangiitis (GPA,
Wegen
-
2024-511862-35-00
4
2019-07-19
Adults with non-contrast-enhancing diffuse brainstem gliomas with non-
-
2024-510580-28-00
5
2019-06-05
Middle or low locally advanced resectable rectal carcinoma
-
2023-504201-36-00
10
2018-12-21
Defined by parent protocol. The study will enroll all adult and paedia
-
2024-514780-26-00
4
2018-10-23
Patients ≤50 years old with high-risk osteosarcoma (defined as metasta
-
2023-505625-14-00
7
2017-01-31
Relapsed/refractory B-cell non-Hodgkin’s lymphoma (r/r NHL)
-
2024-516103-16-00
4
2015-12-04
Acute Lymphoblastic Leukemia (ALL) in younger adults (18-59 years)
-
2024-512222-28-00
10
2015-06-02
Newly diagnosed with an intracranial or spinal ependymoma (all WHO gra
-
2023-506027-29-00
5
2014-10-01
Children, adolescents and adults with newly diagnosed diffuse intrinsi
-
2024-517275-21-00
4
2012-02-20
Retinoblastoma
-
2024-517078-52-00
5
2026-01-19
Patients operated with an IPAA for ulcerative colitis woth active recu
-
2024-516873-57-00
10
2026-01-13
Acute myeloid leukemia in adults aged 18 to 60
-
2022-502305-15-00
7
2025-11-26
Relapsed or refractory B-cell Acute Lymphoblastic
Leukemia
-
2023-506146-23-00
4
2025-11-17
Non-Muscle-Invasive Urothelial Carcinoma (NMIBC) of the Bladder